NLRP3 and diabetic retinopathy: For other eye diseases, including corneal endothelial dysfunction and diabetic retinopathy, HRS demonstrated efficacy by reducing oxidative stress, inhibiting apoptosis, and preserving physiological function through mechanisms involving the NF-κB/NLRP3 and FOXO3a/p53/p21 pathways [21].